The duty to disclose (even more) adverse clinical trial results.
作者信息
Hassoun Nicole
机构信息
Philosophy Department, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
出版信息
Am J Bioeth. 2009 Aug;9(8):33-4. doi: 10.1080/15265160902893874.
PMID:19998155
Abstract
摘要
相似文献
1
The duty to disclose (even more) adverse clinical trial results.
Am J Bioeth. 2009 Aug;9(8):33-4. doi: 10.1080/15265160902893874.
2
The duty to disclose adverse clinical trial results.
Am J Bioeth. 2009 Aug;9(8):24-32. doi: 10.1080/15265160902984988.
3
Disclosing clinical trial results: publicity, significance and independence.
Am J Bioeth. 2009 Aug;9(8):W3-5. doi: 10.1080/15265160903088151.
4
Respecting participant autonomy and the disclosure of clinical trial results.
Am J Bioeth. 2009 Aug;9(8):38. doi: 10.1080/15265160902979806.
5
Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?
Am J Bioeth. 2009 Aug;9(8):45-7. doi: 10.1080/15265160902939933.
6
Compounding risks to patients: selective disclosure is not an option.
Am J Bioeth. 2009 Aug;9(8):35-6. doi: 10.1080/15265160902979798.
7
Improving subject recruitment by maintaining truly informed consent: a practical benefit of disclosing adverse clinical trial results.
Am J Bioeth. 2009 Aug;9(8):36-7. doi: 10.1080/15265160902940048.
8
Precautionary harm disclosure in clinical trials.
Am J Bioeth. 2009 Aug;9(8):43-5. doi: 10.1080/15265160902948348.
9
The duty to register phase I trials.
Am J Bioeth. 2009 Aug;9(8):41-2. doi: 10.1080/15265160902940030.
10
The ethics of disclosing to research subjects the availability of off-label marketed drugs.
Am J Bioeth. 2014;14(4):51. doi: 10.1080/15265161.2014.889943.
引用本文的文献
1
A Call to Accountability: Reporting Outcomes in Vascularized Composite Allotransplantation.
Plast Reconstr Surg Glob Open. 2019 Jun 14;7(6):e2266. doi: 10.1097/GOX.0000000000002266. eCollection 2019 Jun.
Zotero 插件